Biotech IPOs are on a roll, with 2019 shaping up to be a record-breaking year.
Boom or recession, this little stock is a great buy.
Leaving your savings to linger in an account that pays hardly any interest? The longer you let it go on, the worse it gets.
We’re going after the stocks that have had the most insider buying of late. Here's why...
It has gone from a 3-person startup to a commercial lighting and display tech giant with more than 5,000 current or pending patents.
All victims are entitled to 10 years of free credit monitoring, or $125. Here's how to make sure you get yours.
Get them while they're hot
Bitcoin is back
Here are the 5G Stocks to buy now
Fortunately, the twilight end of cannabis prohibition here in the U.S. provides a business climate where the "classic turnaround" can happen easily.